Cumberland Partners’s Boston Scientific BSX Stock Holding History

Cumberland Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,500	Closed	-$1.42M	–	179
2021 Q4	$1.42M	Buy	33,500 +1,500	+5%	+$63K	0.1%	113
2021 Q3	$1.39M	Sell	32,000 -5,000	-14%	-$221K	0.11%	114
2021 Q2	$1.58M	Buy	37,000 +2,000	+6%	+$84.1K	0.12%	109
2021 Q1	$1.35M	Buy	35,000 +10,000	+40%	+$378K	0.11%	112
2020 Q4	$899K	Buy	25,000 +2,500	+11%	+$90.1K	0.08%	123
2020 Q3	$860K	Sell	22,500 -2,500	-10%	-$96.3K	0.09%	106
2020 Q2	$878K	Buy	25,000 +3,000	+14%	+$108K	0.09%	119
2020 Q1	$718K	Buy	22,000 +4,350	+25%	+$170K	0.09%	111
2019 Q4	$798K	Buy	17,650 +4,150	+31%	+$174K	0.07%	124
2019 Q3	$549K	Hold	13,500	–	–	0.05%	127
2019 Q2	$580K	Buy	+13,500	New	+$519K	0.06%	131

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Cumberland Partners's BSX Position: Q1 2022 in Review

Cumberland Partners sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 33,500 shares — an estimated $1.42M sold.

Cumberland Partners first reported a position in BSX in Q2 2019 and held it in 11 quarters. The position peaked at $1.58M in Q2 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Cumberland Partners reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
Cumberland Partners sold 33,500 Boston Scientific shares in Q1 2022, an estimated $1.42M.
Cumberland Partners first reported a position in Boston Scientific in Q2 2019 and held it in 11 quarters.
Cumberland Partners's Boston Scientific position peaked at $1.58M in Q2 2021.
904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Cumberland Partners's 13F filing for Q1 2022, filed 10 May 2022.